abstract |
The invention relates to a compound of formula X: which modulates the activity of HER2 and / or a mutant thereof, and / or EGFR and / or a mutant thereof, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which HER2 and / or a mutant thereof, and / or EGFR and / or a mutant thereof, is involved. |